Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolande Lievens

Showing results (31-40 of 181) with videos related to

Pageof 19
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2021
Value-based radiotherapy: A new chapter of the ESTRO-HERO projectYolande Lievens, Josep-Maria Borras, Cai Grau, et al.
Frontiers in Oncology|July 5, 2021
Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long StudyLotte Van Der Weijst, Veerle Surmont, Wim Schrauwen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?Noémie Defourny, Chris Monten, Cai Grau, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 4, 2022
Neurocognitive functioning following lung cancer treatment: The PRO-Long StudyLotte van der Weijst, Yolande Lievens, Veerle Surmont, et al.
Critical Reviews in Oncology/Hematology|October 26, 2017
Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?Lotte van der Weijst, Veerle Surmont, Wim Schrauwen, et al.
Critical Reviews in Oncology/Hematology|October 23, 2017
Erratum to "Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?" [Crit. Rev. Oncol. Hematol., 119 (November) (2017) 40-49]Lotte van der Weijst, Veerle Surmont, Wim Schrauwen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2016
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysisNoémie Defourny, Peter Dunscombe, Lionel Perrier, et al.
Frontiers in Oncology|August 29, 2019
Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature ReviewLotte Van Der Weijst, Yolande Lievens, Wim Schrauwen, et al.
Frontiers in Oncology|December 25, 2014
EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond ProgressionKatrijn Van Assche, Liesbeth Ferdinande, Yolande Lievens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
Stereotactic body radiotherapy for lung cancer: how much does it really cost?Yolande Lievens, Caroline Obyn, Anne-Sophie Mertens, et al.
Pageof 19

Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2021
Value-based radiotherapy: A new chapter of the ESTRO-HERO projectYolande Lievens, Josep-Maria Borras, Cai Grau, et al.
Frontiers in Oncology|July 5, 2021
Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long StudyLotte Van Der Weijst, Veerle Surmont, Wim Schrauwen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?Noémie Defourny, Chris Monten, Cai Grau, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 4, 2022
Neurocognitive functioning following lung cancer treatment: The PRO-Long StudyLotte van der Weijst, Yolande Lievens, Veerle Surmont, et al.
Critical Reviews in Oncology/Hematology|October 26, 2017
Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?Lotte van der Weijst, Veerle Surmont, Wim Schrauwen, et al.
Critical Reviews in Oncology/Hematology|October 23, 2017
Erratum to "Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?" [Crit. Rev. Oncol. Hematol., 119 (November) (2017) 40-49]Lotte van der Weijst, Veerle Surmont, Wim Schrauwen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2016
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysisNoémie Defourny, Peter Dunscombe, Lionel Perrier, et al.
Frontiers in Oncology|August 29, 2019
Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature ReviewLotte Van Der Weijst, Yolande Lievens, Wim Schrauwen, et al.
Frontiers in Oncology|December 25, 2014
EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond ProgressionKatrijn Van Assche, Liesbeth Ferdinande, Yolande Lievens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
Stereotactic body radiotherapy for lung cancer: how much does it really cost?Yolande Lievens, Caroline Obyn, Anne-Sophie Mertens, et al.
Pageof 19